BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 31808385)

  • 21. Cancer stem cells and their implication in breast cancer.
    Carrasco E; Alvarez PJ; Prados J; Melguizo C; Rama AR; Aránega A; Rodríguez-Serrano F
    Eur J Clin Invest; 2014 Jul; 44(7):678-87. PubMed ID: 24766664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
    Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
    Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutics strategies against cancer stem cell in breast cancer.
    Ghasemi F; Sarabi PZ; Athari SS; Esmaeilzadeh A
    Int J Biochem Cell Biol; 2019 Apr; 109():76-81. PubMed ID: 30772480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
    Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
    Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer stem cell: the roles and therapeutic implications.
    Yang F; Xu J; Tang L; Guan X
    Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.
    Chen W; Zhang L; Liu S; Chen C
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
    Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
    Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells.
    Wang S; Mou Z; Ma Y; Li J; Li J; Ji X; Wu K; Li L; Lu W; Zhou T
    Biochem Pharmacol; 2015 May; 95(2):98-109. PubMed ID: 25824241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of breast cancer by dietary polyphenols-role of cancer stem cells.
    Gu HF; Mao XY; Du M
    Crit Rev Food Sci Nutr; 2020; 60(5):810-825. PubMed ID: 30632783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene.
    Wu CH; Hong BH; Ho CT; Yen GC
    J Agric Food Chem; 2015 Mar; 63(9):2432-41. PubMed ID: 25686711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradicating the Roots: Advanced Therapeutic Approaches Targeting Breast Cancer Stem Cells.
    He L; Yu A; Deng L; Zhang H
    Curr Pharm Des; 2020; 26(17):2009-2021. PubMed ID: 32183663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling.
    Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L
    Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer stem cells.
    Velasco-Velázquez MA; Homsi N; De La Fuente M; Pestell RG
    Int J Biochem Cell Biol; 2012 Apr; 44(4):573-7. PubMed ID: 22249027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of stemness-related signaling pathways in breast cancer response to therapy.
    Angeloni V; Tiberio P; Appierto V; Daidone MG
    Semin Cancer Biol; 2015 Apr; 31():43-51. PubMed ID: 25153354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
    Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.
    Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H
    Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological targets of breast cancer stem cells: a review.
    Pindiprolu SKSS; Krishnamurthy PT; Chintamaneni PK
    Naunyn Schmiedebergs Arch Pharmacol; 2018 May; 391(5):463-479. PubMed ID: 29476201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Bright Horizon of Intelligent Targeted-cancer Therapy: Nanoparticles Against Breast Cancer Stem Cells.
    Vaez A; Abbasi M; Shabani L; Azizipour E; Shafiee M; Zare MA; Rahbar O; Azari A; Amani AM; Golchin A
    Curr Stem Cell Res Ther; 2023; 18(6):787-799. PubMed ID: 36200213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin.
    Nie G; Cao X; Mao Y; Lv Z; Lv M; Wang Y; Wang H; Liu C
    Int Immunopharmacol; 2021 Jun; 95():107153. PubMed ID: 33677254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.